Search Results - "Schouten, P C"
-
1
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial
Published in Breast cancer research and treatment (01-12-2017)“…Purpose The BRCA1 -like profile identifies tumors with a defect in homologous recombination due to inactivation of BRCA1. This profile has been shown to…”
Get full text
Journal Article -
2
Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation
Published in British journal of cancer (27-05-2014)“…Background: Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several…”
Get full text
Journal Article -
3
Understanding the biology of triple-negative breast cancer
Published in Annals of oncology (01-08-2012)“…Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern the roughly 60% of node-negative patients who are already…”
Get full text
Journal Article -
4
Understanding the biology of triple-negative breast cancer
Published in Annals of oncology (01-08-2012)Get full text
Journal Article -
5
-
6
Expression of XIST and 53BP1 as Predictive Markers in BRCA1 Deficient Breast Cancer
Published in Annals of oncology (01-05-2013)Get full text
Journal Article -
7
Abstract OT1-03-10: A phase I followed by a r andomiz e d phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy v ersus capec i tabine in BRCA-1 or -2 mutated Her2 negative ad v anced breast c a ncer as first l ine treatment (REVIVAL study)
Published in Cancer research (Chicago, Ill.) (15-02-2016)“…Background Preclinical studies revealed that the combination of platinum compounds and olaparib is additive and possibly even synergistic in cell models with…”
Get full text
Journal Article -
8
Abstract P3-07-28: BRCA1-like profile as predictive biomarker in non myeloablative chemotherapy (GAIN study)
Published in Cancer research (Chicago, Ill.) (15-02-2016)“…Background: The BRCA1-like copy number (CN) profile can be used as a biomarker to predict which stage III breast cancer patients benefit from myeloablative,…”
Get full text
Journal Article -
9
Abstract PD3-01: CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2016)“…Triple-negative breast cancer (TNBC) is defined by absent expression of estrogen receptor (ER), progesterone receptor (PR) and non-overexpression of human…”
Get full text
Journal Article -
10
EZH2 is overexpressed in breast tumors with a BRCA1-like DNA copy number profile
Published in Geburtshilfe und Frauenheilkunde (13-10-2016)“…Purpose: The polycomb group protein EZH2 is an epigenetic repressor and overexpression of EZH2 is associated with highly aggressive types of breast cancer…”
Get full text
Conference Proceeding -
11
EZH2 is overexpressed in breast tumors with a BRCA1-like DNA copy number profile
Published in Geburtshilfe und Frauenheilkunde (13-10-2016)“…Abstract only…”
Get full text
Journal Article -
12
Effects of zinc contamination on a natural nematode community in outdoor soil mesocosms
Published in Archives of environmental contamination and toxicology (01-02-2002)“…The effect of zinc on the indigenous nematode fauna of a sandy soil was determined in an experimentally contaminated outdoor field plot. The aims of the study…”
Get full text
Journal Article